Novel Bispecific CAR-T Cells Against Hematological Cancers
Dr. Vita Golubovskaya, Director of R&D at ProMab will be hosting a webinar with Agilent that incorporates some [...]
News
ProMab Bispecific Antibody Webinar
Interested in learning more about Bispecific Antibody Engineering? ProMab will be hosting a webinar encompassing our Bispecific Antibody [...]
ProMab CAR-T Webinar
ProMab Biotechnologies is the world’s first CRO committed to improving human health with a focus on immunotherapy, specifically [...]
ProMab Presents Promising Results in Humanized CD19 CAR-T Cells Trial
ProMab’s humanized CD19 CAR-T platform is a CAR T-cell therapy approved for adults with treatment of relapsed and [...]
Caribou Biosciences and ProMab Biotechnologies Announce Sale and Assignment Agreement for Humanized scFv Targeting BCMA
BERKELEY, Calif. & RICHMOND, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading CRISPR genome editing company, and ProMab Biotechnologies [...]
Products & Custom Orders for 2019 Novel Coronavirus Research
The 2019 novel coronavirus (2019-nCoV) is a new virus that causes respiratory illness in people and can spread [...]
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
ProMab has recently had our work published in JoVE on the real-time cytotoxicity assay (RTCA) that we use [...]
NantKwest Signs Worldwide License Agreement with ProMab
Initially Launching a Novel, High-Affinity BCMA CAR Targeting NK Cell Development Candidate For Multiple Myeloma, With An Option [...]
CAR-TCR Summit 2019
CAR-TCR Summit 2019 Come visit the ProMab team and learn about our new products & services Booth #50 [...]
ASCO Annual Meeting 2019
ASCO Annual Meeting 2019 Come visit the ProMab team and learn about our new products & services Booth [...]
AACR Annual Meeting 2024
AACR Annual Meeting 2024. Come visit the ProMab team and learn about our new products & services at our booth and poster session. [...]
mRNA in vitro Transcription and LNP for protein, Antibody and CAR Engineering
Vita Goblubovskaya, PhD, discusses advancements in mRNA-LNP technology, including bispecific antibodies and CAR technology [...]
Empowering Immunotherapy: CAR-T/NK Innovations
Join our speakers, Robert Berahovich, PhD and John Sienkiewicz, for an exclusive webinar where we will showcase the latest advancements in CAR-T and CAR-NK cell therapies. [...]